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Abstract
Profiling and structural elucidation of secondary metabolites produced by the filamentous fungus Penicillium chrysogenum
and derived deletion strains were used to identify the various metabolites and enzymatic steps belonging to the
roquefortine/meleagrin pathway. Major abundant metabolites of this pathway were identified as histidyltryptophanyldi-
ketopiperazine (HTD), dehydrohistidyltryptophanyldi-ketopiperazine (DHTD), roquefortine D, roquefortine C, glandicoline A,
glandicoline B and meleagrin. Specific genes could be assigned to each enzymatic reaction step. The nonribosomal peptide
synthetase RoqA accepts L-histidine and L-tryptophan as substrates leading to the production of the diketopiperazine HTD.
DHTD, previously suggested to be a degradation product of roquefortine C, was found to be derived from HTD involving
the cytochrome P450 oxidoreductase RoqR. The dimethylallyltryptophan synthetase RoqD prenylates both HTD and DHTD
yielding directly the products roquefortine D and roquefortine C without the synthesis of a previously suggested
intermediate and the involvement of RoqM. This leads to a branch in the otherwise linear pathway. Roquefortine C is
subsequently converted into glandicoline B with glandicoline A as intermediates, involving two monooxygenases (RoqM
and RoqO) which were mixed up in an earlier attempt to elucidate the biosynthetic pathway. Eventually, meleagrin is
produced from glandicoline B involving a methyltransferase (RoqN). It is concluded that roquefortine C and meleagrin are
derived from a branched biosynthetic pathway.
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Introduction
Fungi produce a variety of secondary metabolites, which have
diverse activities, ranging from natural antibiotics to simple toxins
or immunosuppressants [1]. Most of these metabolites are
synthesized either by nonribosomal peptide synthetases (NRPS)
or polyketide synthases (PKS) and can be further modified by a
range of biosynthetic enzymes. The genes encoding the NRPS or
PKS and the modifying enzymes are usually located in the same
genetic region and are often co-expressed [2,3]. Several methods
have been developed to identify the secondary metabolite
biosynthetic gene clusters and their respective products. Key
methods are heterologous gene expression, bioinformatics identi-
fication of gene clusters by methods such as SMURF [4] and
genome mining strategies in which core synthetase genes are
deleted and changes in metabolite production are identified by
comparative metabolite profiling [5].
Secondary metabolites genes and/or their clusters were
frequently transferred from one organism to another during
evolution [6,7]. Also different organisms may produce similar
metabolites [8]. Various fungal species were reported to produce
diketopiperazines, a class of pharmaceutically important naturally
produced secondary metabolites [9,10]. Roquefortine C, a
diketopiperazine that was first isolated from Penicillium roquefortine
[11] has now been reported from 25 different Penicillium species
[12]. It displays bacteriostatic activity against Gram-positive
bacteria [13]. Although the exact mechanism of action is not
known it appears to interact with cytochrome p450 and interferes
with RNA synthesis [14,15]. Roquefortine C also shows neuro-
toxic activity in mice and is considered as a contaminant in blue
cheese [16,17]. Meleagrin, a downstream product of roquefortine
C, has been proposed to be the precursor of neoxaline, a
compound with antimicrobial activity [18].
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The filamentous fungus P. chrysogenum has been explored for
more than eighty years for its excellent fermentation capacity
and penicillin production [19,20]. In recent years, genome
sequencing, as well as microarray analysis in combination with
genetic modification of P. chrysogenum, has provided a strong
base to elucidate the role of the secondary metabolite clusters
found in this organism. The genome of P. chrysogenum encodes
20 putative PKS and 11 NRPS genes including the gene
encoding d-(L-a-aminoadipyl)-L-cysteinyl-D-valine synthetase in-
volved in penicillin biosynthesis [21]. This allowed us to identify
the corresponding biosynthetic genes of the roquefortine/
meleagrin pathway using a gene deletion strategy as well as
quantitative metabolite profiling. Here, we revisit an earlier
proposal for a linear pathway for the biosynthesis of
roquefortine C that included several ambiguities as well
speculations because of incomplete metabolite profiling and
enzyme miss assignment. We have elucidated the entire
biosynthetic pathway up to meleagrin production including a
series of precursors that were structurally analyzed. It is
demonstrated that meleagrin is derived from a branched




HPLC-grade acetonitrile and methanol were purchased from
Biosolve (the Netherlands). Dichloromethane, formic acid the
internal standards reserpine, ranitidine and ampicillin were
acquired from Sigma-Aldrich (St. Louis, MO). Meleagrin and
neoxaline were purchased from Bio-Connect (the Netherlands).
Roquefortine C was obtained from Bioaustralis (Australia). L-
Tryptophan, L-Histidine and Mevalonic acid Lactone were
purchased from Sigma-Aldrich. All purchased compounds were
of highest available purity.
B. Host Strains, Media, Grown Condition and Plasmid
Construction
P. chrysogenum strain DS54555, which lacks penicillin cluster
genes and Ku70 gene was used as a host strain for deletion analysis
and was kindly supplied by DSM Anti-infective. All the strains
were grown on YGG-medium [22] for protoplasts formation and
transformation. For analysis, cells were grown on SMP medium
(glucose, 5.0 g/l; lactose, 75 g/l; urea, 4.0 g/l; Na2SO4, 4.0 g/l;
CH3COONH4, 5.0 g/l; K2HPO4, 2.12 g/l; KH2PO4, 5.1 g/l) for
secondary metabolites production using a shaking incubator at
200 rpm for 168 hours at 25uC. Deletion plasmids were
constructed by amplifying the flanking regions of the targeted
gene with the Multisite GatewayHThree-Fragment Vector Con-
struction Kit (Invitrogen). Escherichia coli DH5a was used as host
strain for high frequency transformation and plasmid DNA
amplification [23]. Tryptophan, histidine and mevalonic acid
lactone were dissolve in the same phosphate buffer as used in the
culture medium.
C. Transformation Procedure
Deletion plasmids were transformed to the protoplasts of P.
chrysogenum strain DS54555 [24]. The phleomycin resistance gene
was used as selection marker for the deletion of roqA, roqT and roqD
while acetamidase gene (amdS) was used as selection marker for the
deletion of roqM, roqO, roqN and roqR using acetamide as the only
nitrogen source for selection [22,25].
D. Genomic DNA Extraction, Total RNA Extraction and
cDNA Amplification
Genomic DNA (gDNA) was isolated after 96 hours of growth on
SMP medium using the modified yeast gDNA isolation protocol
[26] in which the fungal mycelium is broken in a FastPrep FP120
system (Qbiogene). Isolated gDNA was measured using a
NanoDrop ND-1000 and 5 mg was used for southern hybridiza-
tion. Total RNA of the host strain was isolated after 168 hours of
growth in SMP medium using Trizol (Invitrogen), with additional
DNase treatment using the Turbo DNA-free kit (Ambion). Total
RNA was measured with the NanoDrop ND-1000 and a
concentration of 500 ng per cDNA reaction was used. cDNA
was synthesized using the iScript cDNA synthesis kit (Bio-Rad) in a
10-ml end volume.
E. Southern Blot Confirmation
gDNA of the host and various deletion strains was isolated using
the E.Z.N.A. Fungal DNA kit (Omega Bio-tek). Southern blotting
was carried out by digesting gDNA (5 mg) with the indicated
restriction enzymes. Digested DNA fragments were separated on a
0.8% agarose gel and blotted onto a Zeta-Probe membrane
(Biorad) described earlier [27], and hybridized with the indicated
probes that were DIG labeled.
F. qPCR Analysis
The primers used to analyze the expression of all the genes in
the Roquefortine/Meleagrin biosynthetic gene cluster i.e.
Pc21g15480 (roqA), Pc21g15420 (roqT), Pc21g15430 (roqD),
Pc21g15440 (roqT), Pc21g15450 (roqN), Pc21g15460 (roqO) and
Pc21g15470 (roqR) were designed around an intron to avoid
amplification on gDNA (Table S3). For expression analyses, the c-
actin gene was used as a control for normalization. A negative
reverse transcriptase (RT) control was used to determine the
gDNA contamination in isolated total RNA. The expression levels
were determined in triplicate with a MiniOpticon system (Bio-
Rad) using the Bio-Rad CFX manager software, with in which the
threshold cycle (CT) values were determined automatically by
regression. The SensiMix SYBR mix (Bioline) was used as a
master mix for qPCR with 0.4 mM primers. The following
thermocycler conditions were used: 95uC for 10 min, followed by
40 cycles of 95uC for 15 s, 60uC for 30 s, and 72uC for 30 s.
Subsequently, a melting curve was generated to determine the
specificity of the qPCRs.
G. Microarray Methods
Triplicate shake flask cultivations were performed with the P.
chrysogenum strain DS17690 to prepare a proprietary DNA
microarray, using the Affymetrix Custom GeneChip program
(Affymetrix): After 90 hours of cultivation, samples from shake
flask cultures were filtered within seconds and quenched in liquid
nitrogen. A standard protocol using Trizol reagent (Invitrogen)
and acid phenol-chloroform was used to extract the total RNA
followed by cDNA synthesis and cRNA synthesis. Hybridized
arrays were scanned and analyzed using the Affymetrix GeneChip
Operating Software (GCOS, Affymetrix) as described earlier by
van der Berg et al. [21].
H. HPLC-MS Validation and Analysis
1. Sample preparation. All strains used for gene assign-
ments were grown in quintuplicate according to the procedure
described above. Samples for determination of growth curves were
grown in eight replicates whereas feeding experiment samples
were grown in quadruplicate. Up to 50 mL of a thawed
Roquefortine Biosynthesis in Penicillium
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fermentation broth, 8 mL internal standard mixture containing
855 nmol/mL ranitidine, 657 nmol/mL reserpine and
1144 nmol/mL ampicillin was added. Subsequently, 230 mL of
methanol was added for protein precipitation and vortexed for 10
minutes. The sample was then centrifuged at 14,000 g for 10
minutes at 10uC. 100 mL supernatant was transferred to an
Eppendorf vial and evaporated for 30 minutes in a Thermo-
Speedvac (Thermo Scientific, San Jose, CA). The dried sample
was redissolved in 100 mL water containing 2% acetonitrile,
vortexed for 10 minutes and transferred to an autosampler vial.
2. Reversed-Phase LC-MS. For separation, an Agilent 1200
Capillary pump (Agilent, Santa Clara, CA) coupled to a Surveyor
PDA detector (Thermo Scientific, San Jose, CA) and LTQ-FT
Ultra mass spectrometer (Thermo Scientific, San Jose, CA) were
used. A sample of 5 mL was injected onto a Waters Atlantis T3
column (2.16100 mm, 3 mm) (Waters, Milford, MA). The elution
was performed with a linear gradient starting with 98% of solvent
A (1% acetonitrile and 0.1% formic acid in water) and 2% solvent
B (1% water and 0.1% formic acid in acetonitrile) for 1.5 minutes
at a flow rate of 300 mL/min. The first linear gradient reached
40% B at 22 minutes, the second 100% B at 25 minutes. The
column was flushed for 10 minutes at 100% B followed by
equilibration for 8 minutes at 100% A. The column effluent was
directed to the ESI-LTQ-FT Ultra MS, operated in full scan (m/z
100–2000) in pos/neg switching mode with following settings:
Positive ion mode (4 kV source voltage, 14 V capillary voltage,
65 V tube lens), negative ion mode (3 kV source voltage, 218 V
capillary voltage, 285 V tube lens) with capillary temperature
275uC, sheath gas flow 50 and auxiliary gas flow 2.
3. Data processing. Raw files were sliced into UV-trace,
positive and negative mass trace and subsequently converted into
NetCDF, using an in-house tool programmed in MATLAB
(MathWorks, Natick, MA). NetCDF files with same polarity were
subsequently deconvoluted in DataAnalysis 4.0 (Bruker Daltonik,
Bremen, Germany) using the dissect function which was controlled
through a macro. The resulting peak tables for each sample were
combined and repeating features removed. The combined feature
table was used as target list in which each feature was integrated in
every individual sample. Samples were grouped regarding their
biological origin and statistical tests were performed for determi-
nation of significant differences. Discovered features were selected
and transferred to LCquan v2.6 (Thermo Scientific, San Jose, CA)
for more accurate integration. Peaks were auto-integrated using
base peak trace in a mass range of 10 ppm and retention time
window of 60 seconds and manually corrected if necessary.
I. Secondary Metabolite Identification
The identity of 7 and 4 was confirmed by comparing retention
time and HR-MSn spectra of samples to commercially available
standards. The structure of 1 was determined by Mass Spectrom-
etry (MS2 fragmentation and fragmentation tree comparison) as
will be detailed elsewhere which was adapted from the metabolite
identification pipeline developed with the Netherlands Metabo-
lomics Centre [28,29].
Compound 3, 2 and 6 were identified by NMR. 3 and 6 were
extracted based on a modified method of Ohmomo [30]. A P.
chrysogenum culture filtrate was made alkaline with 25% ammonium
hydroxide (pH 10) and extracted with dichloromethane. The
alkaline dichloromethane layer was evaporated to dryness,
redissolved in water containing 50% acetonitrile, vortexed,
centrifuged and transferred to an autosampler vial for fraction
collection via preparative reversed phase LC on an Atlantis T3
column (106100 mm, 5 mm ) (Waters Milford, MA). Compound 2
was extracted following the isolation procedure above except using
ethylacetate as extraction solvent instead of dichloromethane.
NMR spectra were recorded on a Bruker Avance III 700 MHz
NMR spectrometer, equipped with a 5 mm TCI probe. Samples
were dissolved in 0.6 mL DMSO/CDCl3 50/50 and acquired at
280 K (2 and 3) and 320 K (6).
Results
Identification of Roquefortine Biosynthetic Gene Cluster
In order to identify the secondary metabolite biosynthetic genes
under shake flask culture conditions, DNA microarray analysis was
performed on the high penicillin yielding P. chrysogenum strain
DS17690 grown in the presence and absence of the precursor
phenylacetic acid (PAA). Most of the secondary metabolite gene
clusters were not expressed or only at low levels [21]. However,
high levels of expression were observed in the absence of PAA for a
gene cluster including the nonribosomal peptide synthetase
PC21g15480 (roqA), and associated genes Pc21g15420 (roqT),
Pc21g15430 (roqD), Pc21g15440 (roqN), Pc21g15450 (roqO),
Pc21g15460 (roqM) and Pc21g15470 (roqR) (Figure 1A). These
genes were all down regulated when the cells were grown in the
presence of PAA and hence are considered as co-regulated in the
genome (Figure 1B). For the remainder of the study these genes
were abbreviated as roq genes because of their involvement in
roquefortine production.
Untargeted Secondary Metabolite Profiling by HPLC-UV-
MS
A robust and sensitive quantitative platform for profiling of
secondary fungal metabolites from culture broth was developed,
validated and applied. As the majority of these compounds are
unknown and often present at low concentrations only, the
method should be sensitive and provide a high degree of
versatility. Herein, we used a high resolution HPLC-UV-MS
method with positive/negative ionization switching in combina-
tion with UV to allow for the detection of several thousand
features. To extract these features from the acquired data, a
combination of commercial software packages and in-house scripts
were used for untargeted peak discovery and automatic peak
integration. By applying a deconvolution algorithm, fragments,
adducts and cluster ions as well as their isotopes were grouped and
altogether represented mainly by the most abundant ion in the
resulting target list which facilitated further data analysis.
The method was validated in which several analytical perfor-
mance characteristics were determined, but here merely the most
important outcomes are reported. As secondary metabolites from
the roquefortine/meleagrin pathway showed much higher ioniza-
tion efficiency in the positive ion mode, only this polarity is
described here. For the determination of linear dynamic range,
sensitivity and reproducibility, retention times and signal intensi-
ties were evaluated for the used (internal) standards at multiple
concentrations. These standards comprised of commercially
available compounds from the meleagrin/neoxaline pathway
(neoxaline, meleagrin and roquefortine C) and a non-related
non-endogenous compound (ranitidine), which was used as
internal standard. Retention time variations for the standards
and several ‘‘unknown’’ endogenous compounds, which are spread
over the entire chromatogram of 35 minutes, were limited to
maximal 7 seconds (500 injections over 2 weeks of time). The
method proved to be linear for each of the standards over at least 3
orders of magnitude (R2 ranged from 0.998–0.999 in both,
academic and spiked matrix samples) in the appropriate concen-
tration range. Associated Limit of Detections (LOD’s) were
Roquefortine Biosynthesis in Penicillium
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Figure 1. Organization of the roquefortine/meleagrin biosynthetic gene cluster and transcriptomic analysis. (A) Roquefortine/
meleagrin biosynthetic gene cluster and their orthologs in phylogenetically relative species. Homologous proteins are indicated with the same color.
(B) Microarray analysis of the roquefortine biosynthetic genes in P. chrysogenum DS54555 using shake flask culture conditions in the absence (2) or
presence (+) phenylacetic acid (PAA). (C) Correlation between the expression level of roqA and the concentration of the product HTD (1) present in
the growth media. The concentration of 1 was determined by HPLC-UV-MS.
doi:10.1371/journal.pone.0065328.g001
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determined from internal standard corrected calibration lines (8
levels) and ranged from 3–248 nM, depending on the compound
of interest. Due to the absence of endogenous material in the roqA
deletion strain used for validation, absolute quantitation at the
reported low levels is realistic.
The recovery of the method was determined primarily by the
extraction of the spiked compounds from the matrix, i.e.,
fermentation broth. Recoveries ranged from 88% (rsd 7.8%) to
55% (rsd 2.9%) depending on the compound. However, repro-
ducibility measurements showed that both within day and between
day reproducibility are well below 15%. In summary, the
analytical profiling platform developed here is characterized by
good reproducibility and linearity, high coverage and high
sensitivity reaching nanomolar levels.
Metabolite Profiling of the Culture Broth of a P.
chrysogenum Strain with a Deletion of the Nonribosomal
Peptide Synthetase Gene roqA
In order to identify secondary metabolites synthesized by RoqA,
its gene was deleted and comparative metabolite profiling was
performed on the culture supernatant of the host and deletion
strain. RoqA is specified by a 7.45 kbp long gene that translates
into synthetase (2372 amino acids) with the typical domain motifs
of nonribosomal peptide synthetases (NRPS). RoqA comprises two
adenylation (A), thiolation (T) and condensation (C) domains
arranged as ATCATC (Figure 1A) [21]. A host strain P.
chrysogenum DS54555 was used which derived from a DS17690
strain lacking the Ku70 gene and thus competent for homologous
recombination. The DS54555 strain lacks all penicillin biosyn-
thetic genes clusters, which facilitates the identification of
unknown secondary metabolites in the culture broth as the profile
is no longer dominated by b-lactam compounds. RoqA was deleted
by homologous recombination using the deletion plasmid pDEST
R4-R3a (see Figure S1A available online) containing the
phleomycin resistance gene surrounded by flanking regions of
roqA. The deletion of roqA was confirmed by southern blot
hybridization (Figure 2A). The host and DroqA strain were grown
for 168 hours in secondary metabolite production medium (SMP
Medium) and comparative metabolite analysis of these strains was
carried out by HPLC-UV-MS (Figure S2). This revealed the loss
of several secondary metabolites in the deletion strain as compared
to the host strain. These metabolites were identified as histidyl-
tryptophanyldiketopiperazine (HTD) (1), dehydrohistidyltrypto-
phanyldiketo-piperazine (DHTD) (2), roquefortine D (3), roque-
fortine C (4), glandicoline B (6) and meleagrin (7). The structures
of all compounds, except 1 and 4 were confirmed by LC-MS/MS
analysis and subsequent fragmentation spectra, by retention time
comparison with their extracted standards as well as by NMR
(Figure 3, Figures S3, S4, S5 and S6, Table S1). The m/z value for
the compound 1 identified as HTD was observed at 324.144
dalton representing the protonated molecule MH+ with formula
C17H18N5O2. Its chemical structure was elucidated using LC-MS/
MS and high-resolution multi-dimensional fragmentation tree
comparison (in preparation). In addition, a protonated molecule
MH+ at m/z 404.171 and formula C22H22N5O3, which coincides
with the protonated form of glandicoline A (5), was observed to be
Figure 2. Southern blot analysis for deletion of the genes in the roquefortine/meleagrin pathway. Southern blot hybridization was
performed with total DNA extracted from P. chrysogenum DS54555 strains with a deletion of the following genes: roqA (A), roqR (B), roqD (C), roqM
(D), roqO (E), roqN (F) and roqT (G). The DNA was digested with the restriction enzymes as indicated in the schemes.
doi:10.1371/journal.pone.0065328.g002
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present in the host strain but absent in the deletion strain.
Although, a full structure elucidation could not be performed,
parts of the structure were identified by LC-MS/MS which
indicated consistency with the chemical structure of glandicoline A
(e.g. dimethylallyl group) (Figure S3E). Hence, this ion was
assumed to correspond to protonated glandicoline A. In conclu-
sion, the loss of the identified secondary metabolites in the deletion
strain proves unequivocally that RoqA is responsible for the initial
reaction in the roquefortine/meleagrin pathway by combining L-
tryptophan and L-histidine to 1.
Biochemical Analysis of P. chrysogenum Harboring a
Deletion of the roqR Gene
In order to elaborate the putative associated genes of the
roquefortine/meleagrin biosynthetic pathway, the roqR gene
encoding a putative cytochrome P450 oxidoreductase was deleted.
Herein, a linearized deletion plasmid pDEST R4-R3r (Figure
S1B) was transformed into the protoplast of the host strain using
the Aspergillus nidulans acetamidase gene (amdS) for the positive
selection of transformants growing on media with acetamide as a
sole nitrogen source. The homologous recombination resulted in
the complete deletion of the roqR gene as demonstrated by
Southern blot hybridization (Figure 2B). Both the host and DroqR
strains were grown as described above. Deletion of roqR resulted in
an accumulation of compound 1 and 3 while 2, 4, 5, 6 and 7 were
completely absent in the HPLC-MS profile of the DroqR strain
(Figure 4A). These data suggest that 1 is a precursor of 2 resulting
in a branch of the initially proposed linear pathway.
Biochemical Analysis of P. chrysogenum with a Deletion
of the roqD Gene
RoqD shares high sequence homology with dimethylallyltryp-
tophan synthetase (DMATs). Transcriptional analysis of roqD
showed high expression in the host strain grown in the absence of
PAA in shake flasks (Figure 1B). To examine the role of RoqD in
the biosynthesis of roquefortine and related metabolites, its gene
was deleted with plasmid pDEST R4-R3d (Figure S1C) using
phleomycin as a selection marker (Figure 2C). The deletion strain
accumulated high levels of 1 (Figure 4B) in the culture broth as it
was unable to add the dimethylallyl group needed for the
conversion from 1 to 3. Moreover, the biosynthesis of the other
(downstream) metabolites 3 until 7 did not occur, while 2, which is
similar in structure to compound 1, was six times higher in
concentration as compared to the host strain. In combination with
the roqR gene deletion, we conclude that RoqD is responsible for
the conversion of 1 to 3 (see Discussion).
Biochemical Analysis of P. chrysogenum Strains with a
Deletion of roqM, roqN and roqO Gene
RoqM shows homology to MAK1-like monooxygenases. Its
gene was deleted with the deletion plasmid pDEST R4-R3m
(Figure S1D) using amdS as selection marker (Figure 2D). The
deletion of roqM led to substantial accumulation of 3 and 4
compared to the host strain whereas (downstream) metabolites like
5 till 7 were not detected (Figure 4C). This demonstrates that roqM
is involved in the synthesis of 5 using 4.
RoqO shows homology to cytochrome P450 monooxygenases,
and its gene was deleted using plasmid pDEST R4-R3o (Figure 2E,
Figure S1E) using amdS as selection marker. Metabolite profile
comparison of the host and deletion strain showed similar
concentrations of 5 and its upstream metabolites in both strains
(Figure 4D). The absence of 6 and 7 in the deletion strain suggests
5 as final product and therefore indicates a role of roqO in the
biosynthesis of 5 to 6.
RoqN specifies a putative methyltransferase. pDEST R4-R3n
(Figure S1F) was used for the deletion of roqN using amdS for the
positive selection of transformants (Figure 2F). The deletion of roqN
resulted in the loss of 7 in fermentation broth (Figure 4E). In
addition, the concentration of 6 was increased sixty times
compared to the host strain. This increase confirms that RoqN
is responsible for the conversion of 6 to 7 [31].
Biochemical Analysis of P. chrysogenum Harboring a
Deletion of the roqT Gene
RoqT shows high sequence homology with transporters of the
major facilitator superfamily. The gene was removed from the
genome (Figure 2G) using deletion plasmid pDEST R4-R3t
(Figure S1G) and phleomycin as selection marker. Remarkably,
the strain with a deletion of roqT did not show any marked changes
in the metabolite profile as compared to host strain (Figure 4F),
except that the production of 3 was increased five times whereas
production of 4 was decreased by 60%. This indicates that roqT is
not essential for the biosynthesis of 1 till 7.
Gene Expression and Secondary Metabolite Production
To relate the extracellular metabolites of the roquefortine/
meleagrin pathway to the expression levels of the biosynthetic
genes, the host strain was grown for 216 hours in secondary SMP
medium. Total mRNA extraction and extracellular metabolites
Figure 3. Total ion chromatogram for culture broth of P. chrysogenum. Total ion chromatogram (TIC, black) and normalized extracted ion
chromatograms (EIC, colored) of secondary metabolites from the roquefortine/meleagrin pathway in the culture broth of P. chrysogenum DS54555.
HTD (1, 8.8 min), DHTD (2, 9.4 min), glandicoline A (5, 16.8 min), roquefortine D (3, 18.3 min), glandicoline B (6, 18.4 min), meleagrin (7, 19.6 min),
roquefortine C (4, 21.4 min).
doi:10.1371/journal.pone.0065328.g003
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Figure 4. Internal standard corrected concentrations (RR = response ratio) of secondary metabolites from roquefortine/meleagrin
pathway. The metabolite concentrations in the culture broth of the DroqR (A), DroqD (B), DroqM (C), DroqO (D), DroqN (E) and DroqT (F) strains was
compared to the host strain P. chrysogenum DS54555.
doi:10.1371/journal.pone.0065328.g004
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analysis were carried with samples collected during growth. The
metabolite concentrations were determined by HPLC-UV-MS,
while transcript levels were determined by quantitative PCR using
c-actin as reference gene (Figure 1C, Figures S7 and S8). The
expression levels of the various biosynthetic genes increased linear
in time, except for roqA that was found to be highly up-regulated
after 96 hours when the cells are in the late log phase. The
concentration of metabolite 1 synthesized by RoqA increased
almost equally with the expression levels of roqA (Figure 1C), while
after 192 hours the concentrations of metabolites 5 till 7 in the
media decreased (Figure S7 and S8). The concentration of 4
dropped significantly already after 168 hours. The production of
all metabolites was particularly high after 96 hours of growth. It is
concluded that the production of these metabolites is a late event
during growth and that it correlates with the expression of the
respective biosynthetic genes.
Precursor Feed Stimulates Metabolite Production
To evaluate the role of the predicted precursors in roquefor-
tine/meleagrin pathway and related metabolites production,
feeding experiments were performed. L-Tryptophan, L-histidine
and mevalonic acid lactone were added individually and in
combination (at high and low concentration, i.e., 30 and 10 mM
respectively) to the cultures. Since the production of 7 and most of
its derivatives is most significant around 96 hours of growth,
precursors were added at that time point. Filtered supernatants
were analyzed on HPLC-UV-MS after 168 hours of growth. The
metabolites concentrations were dry weight corrected and
compared via t-test to samples without precursors addition. The
concentration of metabolites 1 till 7, except 4 increased with the
addition of 10 mM tryptophan (Figure 5). Addition of 30 mM
tryptophan increased the production of 1, 2, 3, 5 and 7 while
addition of histidine, mevalonic acid lactone and combinations of
tryptophan and histidine did not reveal any significant increase.
These data suggest that the roquefortine biosynthetic pathway is
limited by the availability of tryptophan.
Discussion
Here we have elucidated the biosynthetic pathway of P.
chrysogenum responsible for the production of roquefortine, melea-
grin and related compounds. Through a combined metabolic
profiling, MS- and NMR based structure elucidation and gene
inactivation analysis (7 genes in total, including a transporter-
encoding gene); individual genes could be assigned to the various
biosynthetic steps. The architecturally complex roquefortine and
meleagrin scaffolds are synthesized from simple building blocks,
i.e. histidine and tryptophan.
RoqA is a di-modulated NRPS, containing two adenylation
domains [21] responsible for the condensation of tryptophan and
histidine to produce 1, a diketopiperazine. The roqA deletion strain
no longer produced any of the roquefortine related metabolites (1
till 7 absent from the broth) which was also recognized by Garcı́a-
Estrada et al. [31]. Therefore, roqA encodes the core enzyme
initiating the biosynthesis of 1 till 7 and it is present in all species
reported to produce these compounds [12,33]. RoqD encodes a
dimethylallyltryptophan synthase catalyzing the reversed prenyla-
tion of 1 at the C3 position in its indole moiety utilizing
dimethylallyl diphosphate derived from mevalonic acid lactone of
the mevalonate pathway to form 3 (Figure 6). In addition, it also
catalyzes the ring closure between C2 and N14 of the diketopi-
perazine moiety [34]. Both conversions seem to occur simulta-
neously, similar to the formation of aszonalenin from benzodia-
zepinedione, as no intermediate could be observed [35]. No
prenylated cyclo-histidyltryptophanyl-diketopiperazine was detect-
ed in both the host and deletion strain in contrast to what has
previously suggested [31]. The latter we attribute to a lack of
convincing analytical evidence that indeed this compound is
formed. Importantly, this resulted in a wrong assignment of RoqD
and RoqM in the biosynthetic pathway. Reduction of 1 at position
C12– C15 of the histidinyl moiety to 2 is carried out by the
cytochrome p450 oxidoreductase encoded by roqR leading to a
previously unknown branch in the pathway. In other studies, 2
was reported as a degradation product of 4 under acidic conditions
and in-vivo [17,36]. However, the accumulation of 2 in the DroqD
strain, despite the absence of 4 unequivocally indicates a different
origin for the production of 2. Two possible reactions of 1 lead to a
branch of the roquefortine/meleagrin pathway, one via oxidation
by RoqR to 2 and further to 4 by dimethylallyl addition by RoqD,
and the other via dimethylallyl addition by RoqD to 3 and further
to 4 via oxidation carried out by RoqR (Figure 6). 2 is therefore
not just a degradation product of 4 but a true biological product of
the roquefortine/meleagrin pathway. The absence of 3 and 4 in
the roqD deletion strain and the absence of 2 and 4 in the roqR
deletion strain strongly support our proposal that 2 is the precursor
of 4 following an isoprene addition by RoqD at 2 to form 4,
similar to the known reaction of 1 to 3 (Figure 6). These
observations are very intriguing as it questions the precursor role
of 3 to 4 in the proposed roquefortine/meleagrin pathway [34]. 3
could be the end of the branch leaving 2 as single precursor for 4 if
Figure 5. Change in production of roquefortine/meleagrin metabolites after precursor addition compared to production in cultures
without addition. Colored cells show mean levels that are significant (P,0.05) different.
doi:10.1371/journal.pone.0065328.g005
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Figure 6. Proposed roquefortine/meleagrin biosynthetic pathway. See text for details.
doi:10.1371/journal.pone.0065328.g006
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RoqD is unable of isoprene addition on 2 to yield 3. Therefore, 2
or 3 or even both can be possible precursors of 4.
Based on the highly significant accumulation of 4 in the roqM
deletion strain and the absence of all downstream metabolites 5 till
7, we concluded that roqM, encoding a MAK 1-monooxygenase
like protein, is involved in the conversion of 4 to 5. This leads to
the conclusion that only one enzyme is involved in this prominent
conversion which combines an oxidation, ring opening and ring
closure in one reaction cascade [37]. A possible mechanism
involves an initial hydroxylation at C9 with a subsequent cleavage
of the bond between C9 and N14, yielding a nine-membered ring
with a keto-group at C9. Further oxidation at N1 of the indole
moiety could lead to the loss of water to generate an imine which is
followed by an attack of N11, ultimately yielding glandicoline A.
Maackiain monooxygenases are known to be responsible for the
minor conversion of Maackiain to 1-Hydroxymackian by the
addition of an oxygen, which differs from the more prominent
reaction from 4 to 5 found here [38]. It should however be
emphasized that the enzyme assignment was initially based on
sequence alignment only. Further definition of the mechanism
requires an enzymological characterization.
Our results also demonstrate an involvement of RoqO in the
conversion of 5 to 6. roqO encodes a p450 monooxygenase that
oxidizes 5 on its tryptophan moiety, resulting in formation of 6.
Remarkably, Garcı́a-Estrada et al. [31]mixed up the reactions
catalyzed by RoqO and RoqM most likely because the lower
concentrations of 6 were not recognized, whereas 5 could not have
been detected at all with the used HPLC-UV approach.
Therefore, these authors also wrongly assigned the biosynthetic
pathway leading to the production of 5 by RoqO and 6 by RoqM.
RoqN shares 99% identity with the UbiE/COQ5 family
methyltransferase in A. origami. Its activity was confirmed by
inactivation of the roqN gene resulting in a loss of 7 concomitantly
with a 60 times increase of 6. Thus 7 is the methylated form of 6,
consistent with an involvement of methyltransferase as earlier
recognized [31].
Finally, roqT encodes a highly expressed member of the
Multifacilitator Super Family of transporters that might be
involved in active transport of some of these metabolites.
However, its deletion had little effect on the metabolic profile
suggesting that passive transport, diffusion or another transporter
might be involved in secretion. It is remarkable that all of the
described intermediates are found in the extracellular broth which
suggests that these compounds effectively diffuse from the cell.
Alternatively, secretion might be mediated by a relative unspecific
export system that has not been identified so far. RoqT might
fulfill a role in the retention of these metabolites (see also below)
but this needs to be investigated further in feeding experiments.
In order to explore the evolutionary context of this gene cluster
among filamentous fungi the roquefortine/meleagrin gene clusters
in various fungi were compared using the antiSMASH algorithm
[32]. Sorting the gene clusters by an empirical similarity score
based on the number of BlastP hits between the predicted proteins
of the gene clusters, gene order conservation and the percentage
identity of the Blast hits resulted in three hits of gene clusters
carrying more than two homologs of genes from the roquefortine/
meleagrin biosynthesis gene cluster. One gene cluster, encoded in
the genome of Neosartorya fisheria, contained three genes closely
similar to genes of the P. chrysogenum roquefortine/meleagrin
biosynthetic pathway (59, 67 and 60% identity with roqA, roqD and
roqO, respectively) (Figure 1A, Table S2). This suggests that N.
fisheria may be capable of synthesizing compounds similar to 1, 2,
3 and 4, using similar biosynthetic mechanisms. A. fumigatus and A.
terreus also have three genes in common with the P. chrysogenum
roquefortine gene cluster (roqA, roqD and roqO). Metabolites
produced by these organisms are likely similar to 1 and 3.
However, the final structures may be different as for instance A.
fumigatus contains at least four additional genes (annotated as
phytanoyl-CoA dioxygenase, cytochrome P450, O-methyltrans-
ferase and cytochrome P450 monooxygenase) that might be
involved in further modifications of these secondary metabolites
(Table S2).
A time scale study for the production of roquefortine/meleagrin
biosynthesis pathway intermediates and products showed an
accumulation of 7 in the fermentation broth over time. After
192 hours of growth the metabolite concentrations reached their
maximum before it declined due to a possible uptake from the
media or degradation. Uptake of intermediates back into mycelia
was previously reported for roquefortine [39] and it was proposed
that these compounds serve as exogenous nitrogen source for
colonial expansion [18]. As tryptophan, histidine and mevalonic
acid lactone are the building blocks of the roquefortine/meleagrin
pathway their effect on the production of 1–7 was determined in
feeding experiments. Although labeling experiments showed the
uptake and incorporation of these precursors [40] only the
presence of tryptophan stimulated secondary metabolite formation
by this pathway (Figure 5). This implies that production is limited
by the availability of tryptophan providing a lead for the
optimization of roquefortine/meleagrin pathway by metabolic
engineering of the shikimic acid or anthranilate route for
tryptophan biosynthesis [41]. On the other hand, histidine
reversed the effect of tryptophan. This might relate to nitrogen-
dependent regulation of gene expression as roquefortine and
related compounds have been implicated as exogenous nitrogen
sources for colonial expansion [18], and histidine is an excellent
nitrogen source for P. chrysogenum. Finally, we are currently
analyzing additional intermediates for structural elucidation. It is
most likely that some of the enzymes of this pathway lack a certain
degree of substrate specificity, which may lead to further
branching and thus a wider palette of roquefortine/meleagrin
related compounds.
Conclusion
Genome sequencing and microarray data analysis revealed
seven genes clustered in the genome of Penicillium chrysogenum which
are highly up regulated in the absence of the penicillin G precursor
phenylacetic acid. These genes are involved in the biosynthesis of
roquefortine/meleagrin metabolites. Complete deletion of all
seven genes and detailed biochemical analysis of respective
mutants strains via HPLC, MS and NMR revealed that
dehydrohistidyltryptophanyldiketopiperazine (DHTD), which
was previously identified as degradation product, is biologically
synthesized and a precursor to Roquefortine C. Two enzymes of
this pathway catalyze more than one reaction i.e. RoqD converts
histidyltryptophanyldiketopiperazine (HTD) to roquefortine D
and DHTD to roquefortine C while RoqR converts HTD to
DHTD and roquefortine D to roquefortine C. Thus meleagrin is
synthesized via a branched pathway rather than a linear
biosynthesis.
Supporting Information
Figure S1 Map of the deletion constructs for roqA,
roqR, roqD, roqM, roqO, roqN and roqT which were
used for deletion. Features of the vectors: Amp, Ampicillin
resistance gene for the selection in E. coli; ori, pUC origin of
replication; attP3, and attP4, Gateway att recombination sites;
Pipns, promoter promoter of P. chrysogenum pcbC gene; Phleomycin,
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resistance gene for selection in fungi. amdS, A. nidulans acetamidase
gene.
(TIF)
Figure S2 Analytical approach in schematic view.
Proteins, present in fermentation broth, were removed during
sample preparation. Samples were analyzed by HPLC-UV-MS
and comparative metabolite profiling performed. Statistical
significant features were extracted using liquid-liquid extraction
(LLE) and semi-preparative HPLC-UV-MS and their structure
elucidated by NMR.
(TIF)
Figure S3 HPLC-MS/MS fragmentation spectra includ-
ing chemical formula and calculated exact mass of the
protonated HTD (A), DHTD (B), roquefortine D (C),
roquefortine C (D), glandicoline A (E), glandicoline B (F)
and meleagrin (G) acquired at LTQ-FT-MS Ultra at 35%
normalized collision energy in positive mode.
(TIF)
Figure S4 1H NMR spectrum of DHTD (2).
(TIF)
Figure S5 1H NMR spectrum of roquefortine D (3). Small
additional peaks are not due to impurities but to a second
conformation of roquefortine D.
(TIF)
Figure S6 1H NMR spectrum of glandicoline B (6).
(TIF)
Figure S7 Internal standard corrected metabolite con-
centration in fermentation broth of P. chrysogenum
AFF393 sampled at multiple time points and determined
by HPLC-UV-MS.
(TIF)
Figure S8 Temporal expression of roquefortine/melea-
grin biosynthetic gene cluster in P. chrysogenum AFF393
grown in shaking flask culture.
(TIF)
Table S1 1H and 13C NMR chemical shifts of DHTD (2),
roquefortine D (3) and glandicoline B (6) in DMSO/
CDCl3 at 320K and 280K, respectively (d in ppm).
(DOCX)
Table S2 BlastP analysis of roquefortine/meleagrine
biosynthetic pathway genes.
(DOCX)
Table S3 Primers designed for gene expression analysis
of roquefortine/meleagrine biosynthetic gene.
(DOCX)
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